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Heidi Misteli, MD; Rachel Rosenthal, MD; Daniel Brandenberger, MD; Daniel Oertli, MD, FACS; 
Andreas F. Widmer, MD; Walter R. Marti, MD, FACS 
OBJECTIVE. To quantify the economic burden of in-hospital surgical site infections (SSIs) at a European university hospital. 
DESIGN. Matched case-control study nested in a prospective observational cohort study. 
SETTING. Basel University Hospital in Switzerland, where an average of 28,000 surgical procedures are performed per year. 
METHODS. All in-hospital occurrences of SSI associated with surgeries performed between January 1, 2000, and December 31, 2001, by the 
visceral, vascular, and traumatology divisions at Basel University Hospital were prospectively recorded. Each case patient was matched to a 
control patient by age, procedure code, and National Nosocomial Infection Surveillance System risk index. The case-control pairs were analyzed 
for differences in cost of hospital care and in provision of specialized care. 
RESULTS. A total of 6,283 procedures were performed: 187 SSIs were detected in inpatients, 168 of whom were successfully matched with a 
control patient. For case patients, the mean additional hospital cost was SwF19,638 (95% confidence interval [CI], SwF8,492-SwF30,784); the 
mean additional postoperative length of hospital stay was 16.8 days (95% CI, 13-20.6 days); and the mean additional in-hospital duration of 
antibiotic therapy was 7.4 days (95% CI, 5.1-9.6 days). Differences were primarily attributable to organ space SSIs (« = 76). 
CONCLUSIONS. Ina European university hospital setting, SSIs are costly and constitute a heavy and potentially preventable burden on both 
patients and healthcare providers. 
Infect Control Hosp Epidemiol 2008; 29:623-629 
Surgical site infections (SSIs) account for 14%—16% of all nos-
ocomial infections in inpatients and are considered the most 
common form of nosocomial infection among surgical pa-
tients.1 A number of risk factors have been associated with the 
onset of SSI, and they can be broadly subdivided into patient-
related characteristics (eg, greater age, poor nutritional status, 
and more numerous and/or more severe combrbid condi-
tions) and surgery-related characteristics (eg, long duration of 
procedure, high wound classification, and absence of antibi-
otic prophylaxis).26 Based on such risk factors, SSI prediction 
scores have been developed that allow the identification of pa-
tients at high risk for developing SSI.5,7,8 For these high-risk 
patients, clinicians can implement appropriate prevention 
strategies and effective measures to diagnose infection and ini-
tiate therapy at an early stage. In addition, in the past few years, 
SSI surveillance systems have been shown to decrease the rates 
of SSI in various countries.1'916 In such systems, clinicians 
share feedback on infection rates with surgical staff and rein-
force adherence to Centers for Disease Control and Prevention 
standards. A nosocomial infection surveillance system was in-
troduced at Basel University Hospital in 1999 to decrease the 
rate of SSI. 
Nowadays, hospital infections, particularly SSIs—which 
are potentially preventable complications directly linked to 
surgery—are considered to reflect the quality of care in a 
hospital. National health systems have increasingly come 
under pressure to reduce costs, and estimating the eco-
nomic burden of SSIs has become a matter of increasing 
interest in terms of healthcare economics.17 Many studies 
have clearly demonstrated the tremendous direct economic 
impact of SSIs on health systems and the indirect impact on 
patients (eg, labor costs due to a loss of productivity).1828 
The magnitude of the economic SSI-related burden, how-
ever, varies widely across various studies, mainly because of 
differences in country-specific healthcare reimbursement 
systems, in the methodology of the surveillance and study, 
and in the heterogeneity of the complications covered.29 
Consequently, the information available in the literature is 
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difficult to apply to any specific hospital setting, such as that 
of a European university hospital. A baseline investigation 
of the resources that may be saved is helpful when introduc-
ing a new SSI surveillance system, to stress the usefulness of 
hospital infection control. 
To quantify the economic and medical burden of SSIs in a 
European university hospital, we conducted a matched case-
control study nested in a larger prospective observational study 
of all surgeries performed between January 1, 2000, and De-
cember 31, 2001, by the visceral, vascular, and traumatology 
divisions at Basel University Hospital. 
M E T H O D S 
Patients and Procedures 
All consecutive surgeries performed between January 1, 2000, 
and December 31,2001, by the visceral, vascular, and trauma-
tology divisions of the Department of Surgery at Basel Univer-
sity Hospital were registered as part of a quality improvement 
program. Operations that involved no incision or a hospital 
stay of less than 24 hours were excluded. The surveillance sys-
tem prospectively collected a total of 82 in-hospital variables, 
including data on age, sex, underlying disease, additional diag-
noses, American Society of Anesthesiologists score, type and 
duration of surgery, wound classification, division where sur-
gery was performed, total number of operations, use of antibi-
otics, and length of hospital stay and intensive care stay before 
and after the operation. 
SSI occurrence, as defined by the Centers for Disease 
Control and Prevention, was prospectively registered by the 
resident surgeon, who completed a nosocomial infection 
surveillance form for each patient. Data were collected on 
the type of SSI, the date of diagnosis, and the type of treat-
ment. Each form was subsequently reviewed and signed by a 
fellow surgeon. All cases showing evidence of SSI were val-
idated by a board-certified infectious diseases specialist on 
the basis of a comprehensive review of patient history, ini-
tial microbiologic results, and outcome for up to 1 year after 
surgery. 
Outpatient follow-up was assessed by consulting outpatient 
electronic medical records and by contacting the primary care 
practitioners who performed clinical follow-up after surgery. 
In the case of missing information, patients were interviewed 
by telephone. This information was used to assess the rate of 
SSI that occurred after hospital discharge and the correspond-
ing rate of hospital readmission. 
Data were recorded on an electronically readable form 
created by Cardiff TELEForm Software (Cardiff TELEForm 
Desktop, version 8.0; Verity). These forms were reviewed 
and completed as necessary using data from the patient's 
medical history. Each completed form was cross-checked by 
a second member of the surveillance team. We used Cardiff 
TeleForm Desktop, version 8.0 (Verity), to scan these data 
sheets and export the data to an Excel file (Excel 2003; Mi-
TABLE i. Baseline Characteristics of Patients in a Matched Case-
Control Study of All Surgeries Performed Between January 1, 2000, 
and December 31,2001, by the Visceral, Vascular, and Traumatology 
Divisions at Basel University Hospital 
Characteristic 
Female sex 
ASA score 
1 
2 
3 
4 
McCabe score 
1 
2 
3 
Past or present smoker 
Diabetes 
Receipt of immunosuppressive drugs 
Receipt of steroids 
Class of insurance 
First 
Second 
Third 
Division where surgery was performed 
Visceral surgery 
Traumatology 
Vascular surgery 
Required emergency procedure 
Receipt of surgical antimicrobial 
prophylaxis 
Exceeded the T value* 
Wound classification11 
Clean 
Clean-contaminated 
Contaminated 
Dirty or infected 
No. (%) of patients 
With SSI 
(n = 168) 
79 (47.0) 
8 (4.8) 
62 (36.9) 
78 (46.4) 
20(11.9) 
130 (77.4) 
26(15.5) 
12(7.1) 
79 (47.0) 
19(11.3) 
12(7.1) 
12(7.1) 
25 (14.9) 
25 (14.9) 
118(70.2) 
89 (53.0) 
44 (26.2) 
35 (20.8) 
46 (27.4) 
130 (75.0) 
63 (37.5) 
60 (35.7) 
45 (26.8) 
35 (20.8) 
28 (16.7) 
Without SSI 
(« = 168) 
79 (47.0) 
5 (3.0) 
53 (31.6) 
91 (54.2) 
19(11.3) 
126 (75.0) 
29 (17.3) 
13 (7.7) 
78 (46.4) 
22(13.1) 
11 (6.6) 
7(4.2) 
24(14.3) 
31 (18.5) 
113(67.3) 
96 (57.1) 
47 (28.0) 
25 (14.9) 
49 (29.2) 
136 (81.0) 
56 (33.3) 
68 (40.5) 
41 (24.4) 
39 (23.2) 
. 20(11.9) 
NOTE. ASA, American Society of Anesthesiologists. 
a
 T is approximately the 75th percentile value (in hours) for the duration of 
surgery, as defined in the National Nosocomial Infection Surveillance (NNIS) 
system.7 
b
 From the NNIS system.7 
crosoft). Data were examined for scanning errors before sta-
tistical analysis. 
No formal power calculations were performed, but data 
on hospital statistics from previous years allowed us to es-
timate that the study should cover approximately 6,000 sur-
geries in 2 years for the analyses to be meaningful, assuming 
an SSI rate of 3%-5%. Furthermore, because of the limited 
funding available to us, we were only able to conduct a study 
that included all consecutive patients during a period of 2 
years. The prospective observational study was approved by 
the human subjects committee, and, because of its observa-
tional design, it was exempt from the requirement that all 
patients provide written informed consent. 
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TABLE 2. Outcome Variables for Case Patients and Mean Differences Between Case and Control Patients, Basel 
University Hospital, January 1, 2001, to December 31, 2001 
Case patients 
Outcome variable Mean value (95% CI) Median value (IQR) 
Difference between case and 
control patients, mean 
(95% CI) 
Hospital costs, SwF 
Patient charges, SwF 
Total duration of 
hospitalization, days 
Duration of postoperative 
hospitalization, days 
Duration of postoperative 
intensive care, hours 
Duration of overall in-hospital 
antibiotic therapy, days 
Duration of intravenous 
antibiotic therapy, days 
52,027 (42,370-61,684) 34,930 (21,960-53,450) 
29,816 (24,855-34,776) 19,870 (10,205-37,111) 
35.9 (31.9-39.9) 
29.0 (25.6-32.5) 
40.3 (25.5-55.2) 
11.6(9.7-13.6) 
8.6 (6.9-10.4) 
29.0 (21.0-44.0) 
22.0 (15.0-38.5) 
13.0 (0-23.0) 
8.0 (1.5-17.0) 
4.0 (0-13.0) 
19,638 (8,492-30,784) 
10,607 (5,055-16,159) 
18.7 (14.2-23.1) 
16.8 (13.0-20.6) 
11.4 (-4.9 to 27.6) 
7.4 (5.1-9.6) 
5.2 (3.3-7.2) 
NOTE. CI, confidence interval; IQR, interquartile range. 
Nested, Matched Case-Control Study 
The collection of cost data was not part of the observational 
cohort study design. To quantify the additional economic bur-
den associated with SSI diagnosed SSI in the hospital, we con-
ducted a matched case-control study nested in the prospective 
observational cohort study. Control patients had to be free of 
SSI and were matched to case patients by age ( ± 5 years), pro-
cedure code, and National Nosocomial Infection Surveillance 
(NNIS) risk index.7 NNIS risk index values range from 0 to 3 
points, with 1 point scored for an American Society of Anes-
thesiologists score of more than 2, with 1 point scored for a 
wound classification of more than 2, and with 1 point scored 
for a duration of surgery greater than T, where T is approxi-
mately the 75th percentile value (in hours) for the duration of 
surgery, as defined in the NNIS system. 
Cost Analysis 
During the study period, the exchange rates for the Swiss franc 
were SwFl = US$0.59 (range, US$0.55-US$0.65), €0.65 
(range, €0.62-€0.70), and £0.40 (range, £0.37-£0.43). Cost 
data for case and control patients were derived from the com-
puterized internal cost and activity accounting database from 
the hospital's finance department. This database directly links 
internal hospital costs with patient charges. Hospital costs re-
flected the costs incurred during a specific hospitalization pe-
riod and were calculated in detail on the basis of reference 
prices for each type of treatment used and time unit spent by 
the attending personnel; they included all overhead costs. The 
reference prices were redefined each year by using the hospi-
tal's annual cost report and included all human (eg, doctors, 
nurses, physiotherapists, secretaries, and others) and material 
(eg, room rates and medication) costs. As average indicators 
for the actual costs, they were not dependent on the insurance 
status of the patient or on the educational degrees or salaries of 
the attending staff, and thus were considered the most suitable 
for cost comparisons. Patient charges, on the other hand, re-
flected the amount that the hospital's business office charged 
health insurance companies and patients. They were based on 
all-inclusive prices (eg, cost per time unit in the surgical ward 
and intensive care unit) and depended strongly on the insur-
ance status and place of residence of the patient. Internal hos-
pital costs usually exceeded external patient charges, except for 
patients with first-class insurance coverage; the difference was 
paid by the city of Basel. Even though patient charges seemed 
far less suitable for cost comparisons in the context of this 
study, they were included in our cost analyses because they 
have been repeatedly used to assess the economic impact of 
SSIs in the past.20'24 
Statistical Analysis 
The main outcome variables of the nested, matched case-
control study were as follows: total duration of hospitalization 
(in days), duration of hospitalization after surgery (in days), 
duration of intensive care stay after surgery (in hours), number 
of operations undergone by the patient, duration of in-hospital 
use of antibiotics (days total and days of intravenous use), pa-
tient charges, and hospital costs. We accounted for the 
matched design by calculating differences in continuous out-
comes of case-control pairs and by using conditional logistic 
regression for binary outcomes, such as use of antibiotics. Be-
cause of the large sample size of 168 pairs of case and control 
patients, we use the strength of the central limit theorem of 
probability theory30 to report mean differences and approxi-
mate 95% confidence intervals (CIs) for continuous outcomes, 
such as costs and days of antibiotic use, although their distri-
bution was skewed. To formally test the null hypothesis (ie, no 
difference in continuous outcomes between case and control 
patients), we used the nonparametric matched-pair Wilcoxon 
signed rank test. Results from conditional logistic regression 
analyses are reported as odds ratios (ORs) and 95% CIs. All P 
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TABLE 4. Comparison of Mean Differences in Study Parameter Values Between Case and Control Patients, Stratified by Division of Surgery 
in Which the Procedure Was Performed 
Visceral surgery (« = ; 
Outcome variable Mean difference (95% CI) 
Traumatology (n = 44) 
Mean difference (95% CI) 
Vascular surgery (n = 35) 
Mean difference (95% CI) P 
Hospital costs, SwF 
Patient charges, SwF 
Total duration of 
hospitalization, days 
Duration of 
postoperative 
hospitalization, days 
Duration of 
postoperative 
intensive care, hours 
Duration of overall 
antibiotic therapy, 
days 
Duration of intravenous 
antibiotic therapy, 
days 
25,410(6,267^4,554) <.001 11,074 (-1,912 to 24,059 .028 
10,027(2,767-17,288) .003 11,341 (-702 to 23,384) .030 
17.5(11.5-23.4) <.001 21.7(14.1-29.2) <.001 
17.2(11.9-22.5) <.001 19.1(12.3-26.0) <.001 
26.9(0.7-53.0) .006 -1.9 (-18.2 to 14.3) .344 
6.2 (3.0-9.4) <.001 9.4 (4.8-13.9) <.001 
5.0(2.1-7.8) <.001 6.2(2.3-10.1) .004 
15,728 (-1,176 to 32,632) .033 
11,157 (-1,989 to 24,303) .069 
18.0 (5.4-30.6) 
12.8 (3.2-22.3) 
7.7 (3.2-12.3) 
4.7 (0.8-8.5) 
.005 
.007 
-11.3 (-47.2 to 24.5) .414 
.008 
.026 
NOTE. P values were determined by the Wilcoxon signed rank test; CI, confidence interval. 
values are 2 sided, and statistical significance was set at the .05 
level. All analyses were conducted using Stata, version 10 
(Stata). 
RESULTS 
Between January 1, 2000, and December, 31, 2001, a total of 
6,540 consecutive invasive procedures were performed for in-
patients. Prospective in-hospital data were collected on 6,283 
(96.1%) of those procedures, and 187 cases of SSI in 186 pa-
tients were detected during the time patients were hospitalized 
(incidence, 2.98%). Of these procedures, we had to exclude 2 
that were performed for a single patient during the same hos-
pital stay and 2 that were performed for patients whose cost 
data were incomplete. Of the remaining 183 case patients (with 
a 1:1 correspondence between patient and procedure), 168 
(91.8%) were successfully matched to a suitable control pa-
tient. The baseline characteristics of case and control patients 
were similar (Table 1). 
The mean and median values of the study parameters for 
case patients and the mean differences between case and 
control patients are shown in Table 2. The mean additional 
hospital cost was SwF19,638 (95% CI, SwF8,492-SwF30,784) 
for case patients. The mean total length of hospitalization for 
case patients was more than double that for control patients 
(35.9 vs 17.2 days; P < .001), and the postoperative length of 
hospitalization for case patients was more than double that for 
control patients (29.0 vs 12.3 days; P < .001), resulting in a 
mean additional postoperative hospital stay of 16.8 days (95% 
CI, 13-20.6 days). The mean number of additional days of 
in-hospital antibiotic therapy was 7.4 days (95% CI, 5.1-9.6). 
Conditional logistic regression analyses showed significantly 
higher odds of receipt of antibiotic therapy for patients with 
SSI, compared to those without SSI (OR, 3.23 [95% CI, 2 .0 -
5.2]; P < .001). Moreover, case patients were approximately 4 
times more likely to have undergone 3 or more surgical proce-
dures during hospitalization (OR, 3.92 [95% CI, 2.1-7.4]; P < 
.001) than were control patients, who were more likely to have 
undergone 1 or 2 procedures, whereas the number of opera-
tions that preceded the SSI-related procedure was distributed 
equally between case and control patients (mean difference, 
0.12 [95% CI, - 0 . 1 to 0.3]; P = .732). 
Using the main study parameters, we calculated the mean 
differences between all 168 case patients and all 168 control 
patients, as well as the mean differences stratified by type of SSI 
(76 organ space, 49 deep, and 43 superficial SSIs), as shown in 
Table 3. The differences between case and control patients 
were mainly attributable to organ space SSIs. The overall mean 
increase in SSI-related hospital costs was 60.6%; there was a 
121% increase for organ space infections, a 13.5% increase for 
deep incisional infections, and a 7.9% increase for superficial 
incisional infections. 
Using the main study parameters, we also calculated the 
mean differences between case and control patients strati-
fied by division of surgery (ie, visceral surgery, traumatol-
ogy, or vascular surgery), as shown in Table 4. Microbiolog-
ical analyses identified the pathogens responsible in 127 
(75.6%) of 168 SSIs. Of these 127 SSIs, 29 (23%) were 
caused by Staphylococcus aureus, 24 (19%) by Escherichia 
coli, 12 (9%) by coagulase-negative staphylococci, 9 (7%) by 
Enterobacter species, and the remaining 53 (42%) by 1 or 
more of 12 different microorganisms. Most importantly, 
there was not a single case of SSI caused by methicillin-
resistant S. aureus (MRSA) in the study. Finally, our surveil-
lance system identified 106 (36.2%) of 293 patient with SSI 
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diagnosed after hospital discharge, and 63 (59%) of these 
106 patients were readmitted. 
DISCUSSION 
This matched case-control study, which involved 168 case pa-
tients with SSI in a prospectively registered cohort of 6,283 
patients who underwent surgical procedures in 2000 and 2001, 
provides observational evidence of the substantial economic 
impact of in-hospital SSIs. In fact, all of the parameters studied 
in the present investigation were strongly influenced by the 
occurrence of SSI. To our knowledge, this is the largest cohort 
of patients to have been prospectively studied in a single Euro-
pean center with respect to this issue. Furthermore, we are 
unaware of any other study assessing as many indirect param-
eters, in combination with both direct patient charges and hos-
pital costs stratified by type of SSI, to quantify the adverse eco-
nomic effects of SSIs. 
There are several reasons, however, to assume that we un-
derestimated the true economic burden imposed by SSIs on 
our hospital. First, the economic implications of the SSIs that 
occurred after hospital discharge were not evaluated in this 
study. With the current global trend toward a shortened hos-
pital stay and outpatient and same-day surgery, an increasing 
proportion of SSI cases occur after the patient is discharged 
from the hospital.31,32 In fact, more than 50% of all cases of SSI 
for certain procedures, such as appendectomy, mastectomy, 
and peripheral bypass surgery, occur after the patient is dis-
charged.33 Outpatients who develop SSI are not being identi-
fied by most SSI surveillance systems in
 Use.
18
"
24,28,34
 Although 
our surveillance system managed to identify 106 patients who 
had SSI diagnosed after hospital discharge, of whom 63 were 
readmitted, we were unable to assess the respective economic 
burden based on the outcome variables that were addressed in 
the present study. Perencevich et al.31 reported a significant 
increase in the use of resources for patients with SSI diagnosed 
after discharge from the hospital, in terms of emergency room 
visits, radiology services, readmissions, and home health aide 
services. Perencevich et al.31 also raised a second concern rele-
vant to our study: the period of cost tracking. The present study 
only assessed direct SSI-related costs to the health system dur-
ing primary hospitalization. We did not assess any further di-
rect costs to the health system after patients with SSI were dis-
charged from the hospital (eg, expenses due to outpatient 
follow-up visits and community nurses). Furthermore, we 
were unable to quantify any indirect costs, such as economic 
losses in connection with patients whose treatment had to 
be postponed as a consequence of the prolonged hospital 
stay of patients who developed SSI, or productivity-linked 
labor costs associated with patient sick leave. Alfonso et al.35 
estimated that only 10% of the total costs of SSIs were 
healthcare-related costs; the remainder were social costs 
and labor-related costs. 
A third issue is the extent to which our findings are generally 
applicable. Given the observational, single-center design of the 
present study, the results may only be valid under the condi-
tions in which they were generated. For example, the emer-
gence of cefuroxime-resistant strains, with MRSA being the 
most common, may strongly influence SSI-related costs. En-
gemann et al.20 showed that methicillin resistance is indepen-
dently associated with increased hospital charges among pa-
tients with SSI due to S. aureus. The absence of MRSA among 
the pathogens responsible for the SSIs identified in the present 
study precluded any economic analysis of such infections. 
MRSA infection is very rare in our institution, with a rate of 
0.14-0.17 infections per 1,000 patient-days, or approximately 
1% of all S. aureus infections. Therefore, the results of this 
study cannot be extrapolated to healthcare centers where 
hospital-acquired MRSA infections constitute a substantial 
problem. Consequently, corroboration of our findings by mul-
ticenter studies is encouraged. 
A final matter involves the matched study design, which can 
potentially produce selection bias if only a subset of cases can 
be included in the analysis because of matching requirements, 
as previously described by Delgado-Rodriguez et al.36 In the 
present study, the vast majority of patients with SSI were in-
cluded (91.8%), and therefore selection bias is hardly likely. 
On the other hand, a matched design is efficient because it 
enables researchers to collect detailed cost data on only a subset 
of all patients and to take account of important factors between 
case and control patients that might lead to cost differences. 
Therefore, it is a tool frequently used to assess the economic 
consequences of SSI.22,23,26,28,34 We conclude by stating that, in a 
European university hospital setting, in-hospital SSI is costly 
and constitutes a substantial and potentially preventable bur-
den for both patients and the healthcare system. 
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